Metformin and Intermittent Fasting: Safety Guide

Metformin and intermittent fasting are increasingly being considered together by people managing type 2 diabetes, PCOS, or weight-related conditions. Metformin is one of the most widely prescribed medicines in the UK, and intermittent fasting has grown in popularity as a dietary strategy. Understanding how these two approaches interact, including their combined effects on blood glucose, potential side effects, and safety considerations, is essential before making any changes. This article explains how metformin works alongside fasting, which schedules may be most suitable, what risks to watch for, and why speaking to a GP or diabetes care team first is strongly advisable.

Can you do intermittent fasting while taking metformin?

Most people taking metformin can practise intermittent fasting, but a GP or diabetes care team should be consulted first, as dietary changes can meaningfully affect blood glucose and medication requirements.

Most people taking metformin can practise intermittent fasting, but it is important to discuss any significant dietary change with a GP or diabetes care team before starting. Metformin is a biguanide medicine used primarily in the management of type 2 diabetes.^[1][2] It is also used in some cases for polycystic ovary syndrome (PCOS), though this use is typically off-label in the UK and should always follow prescriber guidance.^[3][4] Metformin is one of the most widely prescribed medicines in the UK and is generally considered compatible with periods of reduced calorie intake, provided the individual is monitored appropriately.

Intermittent fasting describes a range of eating patterns that cycle between defined periods of eating and fasting. Common approaches include the 16:8 method (eating within an eight-hour window), the 5:2 approach (eating normally for five days and restricting calories on two non-consecutive days), and alternate-day fasting. Each places different demands on the body's glucose regulation, which is relevant for anyone taking a medicine that influences blood sugar.

For people managing type 2 diabetes, dietary changes can meaningfully affect blood glucose levels, and fasting may alter how much metformin is needed. Those taking metformin alone are at relatively low risk of hypoglycaemia compared with people on insulin or sulphonylureas, but individual circumstances vary. A healthcare professional can review the full medication list, assess cardiovascular and renal health, and advise on whether fasting is appropriate.

Intermittent fasting is generally not recommended without specialist input for people who are pregnant, breastfeeding, underweight, frail, or who have a current or past history of an eating disorder. Anyone in these groups should speak to their GP or care team before making any changes to their eating pattern.

Bolt Pharmacy is a GPhC-registered online pharmacy (GPhC registration covers Great Britain; pharmacy regulation in Northern Ireland is the responsibility of the PSNI) offering online weight-management consultations, with prescriber review and pharmacist support, and may be one avenue for people seeking clinical guidance alongside their GP.

How does metformin work alongside a fasting eating pattern?

Metformin suppresses hepatic glucose output, which can complement the glucose-lowering effect of fasting; however, gastrointestinal side effects may worsen when the medicine is taken without food during fasting windows.

Metformin works primarily by reducing the amount of glucose the liver releases into the bloodstream, and this mechanism means it may complement the glucose-lowering effects of intermittent fasting.^[1][2] The medicine also improves insulin sensitivity in peripheral tissues, helping cells take up glucose more efficiently.^[1][2] Unlike insulin or sulphonylureas, metformin does not directly stimulate the pancreas to produce more insulin, which is why it carries a lower inherent risk of causing hypoglycaemia when used on its own.^[5][1]

During a fasting period, the body shifts from using dietary glucose as its primary fuel source towards drawing on stored glycogen and, eventually, fat. This metabolic shift naturally lowers circulating blood glucose. Because metformin is already suppressing hepatic glucose output, the two effects can work in the same direction and may produce greater reductions in blood sugar than either approach alone in some individuals, though the extent of this effect will vary. For people with type 2 diabetes who are trying to improve glycaemic control or support weight management, this combination may be beneficial under appropriate supervision.

Metformin is typically taken with or after food to reduce gastrointestinal side effects such as nausea and diarrhoea. During fasting windows, when no food is consumed, some people find these side effects become more noticeable. Modified-release formulations of metformin, which release the medicine more slowly, may be better tolerated in this context, though any change to formulation requires discussion with and approval from a prescriber.^[2][12] Understanding how the medicine behaves during periods of reduced food intake helps individuals and clinicians plan a fasting schedule that is both effective and comfortable.

What are the risks of low blood sugar when fasting on metformin?

Metformin alone carries a low hypoglycaemia risk, but this rises substantially when combined with sulphonylureas or insulin; people on SGLT2 inhibitors also face an MHRA-highlighted risk of euglycaemic DKA during fasting.

Metformin alone carries a low risk of causing hypoglycaemia (low blood sugar), because it does not directly stimulate insulin secretion. However, the risk increases substantially when metformin is combined with other glucose-lowering medicines, particularly sulphonylureas (such as gliclazide or glipizide) or insulin. Anyone taking these combinations should seek specific medical advice before attempting intermittent fasting, as dose adjustments may be necessary.

People taking SGLT2 inhibitors (such as dapagliflozin, empagliflozin, or canagliflozin) alongside metformin should be aware of an additional risk. The MHRA has highlighted that fasting, very low calorie intake, and reduced carbohydrate intake can increase the risk of diabetic ketoacidosis (DKA) in people taking SGLT2 inhibitors, even when blood glucose levels appear near normal (sometimes called euglycaemic DKA).^[6] Anyone on an SGLT2 inhibitor should discuss fasting plans with their prescriber before starting, and should seek urgent medical attention if they develop symptoms such as nausea, vomiting, abdominal pain, excessive thirst, or rapid breathing.

Symptoms of hypoglycaemia to be aware of include:

• Shakiness or trembling

• Sweating

• Dizziness or light-headedness

• Palpitations

• Confusion or difficulty concentrating

• Pallor

If blood glucose falls during a fast, the UK-standard approach is to consume approximately 15 to 20 g of fast-acting carbohydrate, such as glucose tablets, a small glass of fruit juice, or a sugary drink, then recheck blood glucose after 10 to 15 minutes. Once blood glucose has recovered, follow with a longer-acting carbohydrate snack to help maintain levels. Anyone who loses consciousness or cannot swallow requires emergency assistance: call 999 immediately.

A separate but important consideration is lactic acidosis, a rare but serious complication associated with metformin. The risk is higher in people with significant renal impairment, liver disease, or conditions that cause dehydration. Warning signs can include muscle pain, abdominal pain, difficulty breathing, and severe or unusual fatigue; anyone experiencing these symptoms should seek urgent medical attention. Prolonged fasting, particularly in hot weather or during illness, can lead to dehydration, which may reduce kidney function transiently and affect how metformin is cleared from the body. UK sick-day rules (sometimes referred to by the SADMANS acronym) advise that metformin should be temporarily withheld during episodes of dehydrating illness; the metformin SmPC also highlights dehydration as a risk factor for lactic acidosis.^[10] Staying well hydrated during fasting windows is therefore particularly important for people taking this medicine. Anyone unsure whether to withhold metformin during illness should contact their GP or call NHS 111.

Which intermittent fasting schedules suit people on metformin?

The 16:8 method is generally the most practical schedule, as it allows metformin to be taken with food within the eating window; alternate-day and extended fasting carry greater risks and require close clinical oversight.

The 16:8 method is generally considered the most practical intermittent fasting schedule for people taking metformin, as it involves a daily eating window rather than full-day calorie restriction. By timing the eating window to coincide with meals at which metformin is taken, individuals can continue to take the medicine with food as directed, reducing the likelihood of gastrointestinal discomfort. For example, eating between 10:00 and 18:00 allows metformin to be taken with breakfast and an evening meal within the window.

The 5:2 approach, which involves two days of significant calorie restriction each week, requires more careful planning. On restricted days, blood glucose levels may fall lower than usual, and people on combination therapy (metformin plus a sulphonylurea or insulin) may need to adjust their doses on those days. Any dose adjustment must be made under medical supervision and should not be undertaken without prescriber guidance. Eating small, balanced meals on restricted days, rather than a single large meal, can help maintain more stable glucose levels.

Alternate-day fasting and extended fasting periods of 24 hours or more carry greater risks for people with diabetes and are generally not recommended without close clinical oversight. These approaches can cause more pronounced fluctuations in blood glucose and make it harder to time medication correctly.

Regardless of the schedule chosen, the following practical steps are advisable:

• Monitor blood glucose more frequently when starting a new fasting pattern

• Keep a fast-acting glucose source available at all times

• Maintain adequate fluid intake throughout fasting windows

• Review the fasting plan with a GP or diabetes nurse before beginning

Side effects to watch for when combining metformin and fasting

Gastrointestinal symptoms, fatigue, and light-headedness may worsen during fasting; long-term metformin use also reduces vitamin B12 absorption, so monitoring and nutritionally balanced meals are important.

Gastrointestinal side effects are the most commonly reported adverse effects of metformin, and fasting can make these more pronounced for some people. Nausea, stomach cramps, diarrhoea, and a metallic taste in the mouth are well-documented effects, particularly when metformin is taken without food. During fasting windows, the stomach is empty for longer periods, which may exacerbate these symptoms. Taking metformin at the start of a meal, rather than before it, and using a modified-release formulation where appropriate and agreed with a prescriber, can help manage this.

Fatigue and light-headedness during fasting periods are not uncommon and may reflect normal physiological adaptation to reduced calorie intake rather than a medicine-related effect. However, these symptoms can also be early signs of low blood glucose, so it is worth checking blood sugar levels if they occur, particularly in the first few weeks of combining fasting with metformin.

Long-term use of metformin is associated with reduced absorption of vitamin B12, which can lead to deficiency over time.^[13][14] The MHRA has advised that healthcare professionals should consider periodic monitoring of vitamin B12 levels in patients on long-term metformin, particularly those with symptoms or risk factors for deficiency.^[13] Fasting diets that are not carefully planned may also reduce overall nutrient intake. People combining metformin with intermittent fasting should ensure their eating windows include nutritionally balanced meals and may wish to discuss B12 monitoring with their GP.

Any suspected side effects from metformin can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. If side effects are severe, persistent, or accompanied by symptoms such as muscle pain, difficulty breathing, abdominal pain, or unusual fatigue, contact a GP promptly or call NHS 111 for urgent advice.

Should you talk to your GP before fasting on metformin?

Yes, speaking to a GP or diabetes care team before starting is strongly advisable, as they can review kidney function, HbA1c, and the full medication list to identify risks and advise on any dose adjustments.

Talking to a GP or diabetes care team before starting intermittent fasting on metformin is strongly advisable, particularly for anyone managing type 2 diabetes or taking additional glucose-lowering medicines. A healthcare professional can review current HbA1c levels, kidney function, and the full medication list to identify any factors that might increase risk. They can also advise on whether blood glucose monitoring should be increased during the transition period and whether any dose adjustments are needed.

For people taking metformin for PCOS or other non-diabetic indications, the risks associated with fasting are generally lower, but a conversation with a GP is still worthwhile to ensure the dietary change aligns with the overall management plan. Weight loss achieved through intermittent fasting may itself improve insulin sensitivity and hormonal balance, which could affect how much metformin is needed over time.

Intermittent fasting is not appropriate for everyone. People who are pregnant, breastfeeding, underweight, frail, or who have a current or past history of an eating disorder should not start a fasting regimen without first discussing it with a clinician, as fasting may carry additional risks in these circumstances.

NICE guidance on type 2 diabetes management (NG28) emphasises the importance of structured education and individualised dietary advice.^[15] Many GP practices and NHS diabetes services can refer patients to a dietitian or diabetes specialist nurse who can provide tailored support for combining dietary approaches with medication. NHS 111 can provide urgent advice if concerns arise outside of GP hours, but routine questions about fasting and medication are best addressed in a planned GP appointment.

In summary, intermittent fasting and metformin can be combined safely for many people, but the approach should be personalised, monitored, and supported by clinical guidance rather than undertaken without professional input. Open communication with a healthcare team remains the most important step before making significant changes to diet or medication timing.

Scientific References

1. Metformin 500 mg film coated Tablets.
2. Metformin hydrochloride 500 mg Prolonged-release Tablets.
3. Polycystic ovary syndrome: metformin in women not planning pregnancy (ESUOM6).
4. Polycystic ovary syndrome: metformin in women not planning pregnancy – key points from the evidence (ESUOM6).
5. Type 2 diabetes – treatment summary.
6. SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis.
7. Hypoglycaemia – treatment summary.
8. Package leaflet: Metformin SR.
9. Metformin: a medicine to treat type 2 diabetes.
10. Metformin hydrochloride – drug monograph.
11. Risk of Lactic Acidosis With Metformin Therapy.
12. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
13. Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk.
14. Clinician awareness and implementation of vitamin B12 monitoring in metformin users.
15. Type 2 diabetes in adults: management (NG28).
16. Metabolic Effects of Metformin in Humans. Current Diabetes Reviews.
17. Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology. Current Medicinal Chemistry.

Frequently Asked Questions